Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01972581 · ClinicalTrials.gov registry record · NA
Neurocognitive Visual Reaction Training
A NA study, sponsored by High Point University.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT01972581: Completed NA study, sponsored by High Point University.
NCT01972581 is a NA study that has completed, run by High Point University. The registered enrollment target is 21 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01972581, a NA study, has completed, sponsored by High Point University.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
Incorporating neurocognitive visual reaction training has been shown to increase bating performance in collegiate baseball players. However, poor methodology, such as lack of a control group and use of an unreliable outcome measure, limit the strength of the previous study. Therefore the purpose of this study is to determine the effects of neurocognitive visual reaction training on reaction time and coordination in an athletic population. The purpose of this study is to determine the effects of neurocognitive visual reaction training on reaction time and coordination.
Interventions
- OTHER Reaction Time Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2013-10 |
| Est. Completion | 2016-02 |
| Phase | NA |
What the finished NCT01972581 record still lists
NCT01972581 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Reaction Time Training is the first listed.
NCT01972581 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01972581 about?
NCT01972581 is a clinical study titled "Neurocognitive Visual Reaction Training". Incorporating neurocognitive visual reaction training has been shown to increase bating performance in collegiate baseball players. However, poor methodology, such as lack of a control group and use of an unreliable outcome measure, limit the strength of the previous study. Therefore the purpose of ...
What is the current status of trial NCT01972581?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2013-10. Estimated completion is 2016-02.
What interventions are being tested in trial NCT01972581?
The interventions under investigation include: Reaction Time Training (OTHER).
Who is sponsoring clinical trial NCT01972581?
This trial is sponsored by High Point University, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01972581's enrollment target sits among peer trials
21 1762nd of 2000 higher than 233 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia